Skip to main content
. Author manuscript; available in PMC: 2021 Apr 16.
Published in final edited form as: Inhal Toxicol. 2020 Apr 16;32(3):115–123. doi: 10.1080/08958378.2020.1751750

Table 1.

Description of Study Participants.*

Variable (units) Statistic All
(n=47)
Female (n=22) Male
(n=25)
BMI (kg/m2) Mean [SD]
min, max
23.4 [2.3]
19.4, 28.7
23.5 [2.6]
19.7, 28.7
23.3 [2.0]
19.4, 26.0
Age (years) Mean [SD]
min, max
27.4 [3.6]
20.5, 36.1
27.5 [3.4]
22.8, 34.0
27.4 [3.9]
20.5, 36.1
Number of sessions conducted* Total sessions 269 129 140
Participants with data for all six treatments* Percent 81 86 76
Baseline FVC (liters) Mean [SD]
min, max
4.9 [1.1]
3.1, 8.1
4.2 [0.5]
3.1, 5.4
5.5 [1.0]
4.0, 8.1
Baseline FEV1 (liters) Mean [SD]
min, max
3.9 [0.8]
2.9, 6.1
3.4 [0.4]
2.9, 4.4
4.3 [0.7]
3.3, 6.1
Baseline FEV1/FVC (ratio) Mean [SD]
min, max
0.8 [0.1]
0.6, 1.0
0.8 [0.1]
0.7, 1.0
0.8 [0.1]
0.6, 0.9
Baseline FEF25–75 (liters/s) Mean [SD]
min, max
3.9 [1.1]
2.2, 6.3
3.5 [0.9]
2.2, 5.4
4.2 [1.1]
2.2, 6.3
*

A participant session was counted if they had data for baseline measurement and at least one post-exposure measurement.

Mean of each individuals’ average baseline health measurement across their completed study sessions. Participants were required to have normal spirometry at a pre-study screening exam (results not included here), defined as spirometry values greater than 70% of the predicted value for the age/gender.

Definition of abbreviations: BMI = body mass index; FVC = forced vital capacity; FEV1 = forced expiratory volume in 1 second; FEF25–75 = mid-expiratory flow rate (average rate at 25th-75th percent of the pulmonary volume); SD = standard deviation